Vertex Pharmaceuticals Inc (VRTX): Total Liabilities
$6.98B
As of 2025-12-31
$7.18B
As of 2026-06-30
+18.1%
3-year compound annual growth
+17.9%
5-year compound annual growth
+17.4%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.98B | +13.9% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $6.12B | +18.9% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $5.15B | +21.5% | 2025-02-13, Balance as of period end |
| 2022-12-31 | $4.24B | +27.2% | 2024-02-15, Balance as of period end |
| 2021-12-31 | $3.33B | +8.7% | 2023-02-10, Balance as of period end |
| 2020-12-31 | $3.06B | +37.2% | 2022-02-09, Balance as of period end |
| 2019-12-31 | $2.23B | +23.3% | 2021-02-11, Balance as of period end |
| 2018-12-31 | $1.81B | +20.4% | 2020-02-13, Balance as of period end |
| 2017-12-31 | $1.50B | -3.5% | 2019-02-13, Balance as of period end |
| 2016-12-31 | $1.56B | +10.9% | 2018-02-15, Balance as of period end |
| 2015-12-31 | $1.40B | +13.4% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $1.24B | +28.7% | 2016-02-16, Balance as of period end |
| 2013-12-31 | $962.64M | -36.9% | 2015-02-13, Balance as of period end |
| 2012-12-31 | $1.52B | +23.1% | 2014-02-11, Balance as of period end |
| 2011-12-31 | $1.24B | +1.4% | 2013-03-01, Balance as of period end |
| 2010-12-31 | $1.22B | +42.2% | 2012-02-22, Balance as of period end |
| 2009-12-31 | $859.14M | n/a | 2011-02-17, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $6.98B | +13.9% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $25.99B | -3.2% |
| Viatris Inc (VTRS) | 2025-12-31 | $22.48B | -1.7% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $9.30B | +10.7% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $12.14B | +28.2% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $32.83B | -2.3% |
| Organon & Co. (OGN) | 2025-12-31 | $12.12B | -4.1% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $3.83B | +47.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.81B | +4.5% |
Compare VRTX, BHC, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗